Package 70518-1908-4

{"route": ["ORAL"], "spl_id": "498899e3-66a8-449a-e063-6394a90a026e", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "unii": ["U3H27498KS"], "rxcui": ["282401"], "spl_set_id": ["1b5646a9-4724-44b8-8cd0-9c14f5e87f86"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BLISTER PACK (70518-1908-1)", "package_ndc": "70518-1908-1", "marketing_start_date": "20210402"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (70518-1908-4)", "package_ndc": "70518-1908-4", "marketing_start_date": "20240410"}], "brand_name": "Lamotrigine", "product_id": "70518-1908_498899e3-66a8-449a-e063-6394a90a026e", "dosage_form": "TABLET", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Dihydrofolate Reductase Inhibitors [MoA]", "Mood Stabilizer [EPC]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "product_ndc": "70518-1908", "generic_name": "Lamotrigine", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamotrigine", "active_ingredients": [{"name": "LAMOTRIGINE", "strength": "25 mg/1"}], "application_number": "ANDA090170", "marketing_category": "ANDA", "marketing_start_date": "20190225", "listing_expiration_date": "20271231"}